SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-K’ for 9/30/14

On:  Monday, 12/29/14, at 5:19pm ET   ·   For:  9/30/14   ·   Accession #:  1144204-14-76185   ·   File #:  1-35527

Previous ‘10-K’:  ‘10-K/A’ on 1/28/14 for 9/30/13   ·   Next:  ‘10-K/A’ on 1/23/15 for 9/30/14   ·   Latest:  ‘10-K’ on 3/31/23 for 12/31/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/29/14  Emmaus Life Sciences, Inc.        10-K        9/30/14   70:12M                                    Toppan Merrill/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    750K 
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     37K 
 3: EX-10.89    Material Contract                                   HTML     61K 
 4: EX-10.90    Material Contract                                   HTML     34K 
 5: EX-10.91    Material Contract                                   HTML    107K 
 6: EX-23.1     Consent of Experts or Counsel                       HTML     20K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
49: R1          Document And Entity Information                     HTML     51K 
39: R2          Consolidated Balance Sheets                         HTML    121K 
47: R3          Consolidated Balance Sheets [Parenthetical]         HTML     47K 
51: R4          Consolidated Statements of Operations               HTML    102K 
65: R5          Consolidated Statements of Changes in               HTML    117K 
                Stockholders' Deficit                                            
41: R6          Consolidated Statements of Cash Flows               HTML    140K 
46: R7          Nature of Operations                                HTML     36K 
36: R8          Summary of Significant Accounting Policies          HTML     98K 
27: R9          Discontinued Operations                             HTML     56K 
66: R10         Convertible Debt and Equity Financings              HTML     84K 
53: R11         Derivative Liabilities                              HTML     43K 
52: R12         Stockholders' Deficit                               HTML    335K 
57: R13         Income Taxes                                        HTML     62K 
58: R14         Related Party Transactions                          HTML     86K 
56: R15         Loss Per Share                                      HTML     54K 
59: R16         Commitments and Contingent Liabilities              HTML     61K 
48: R17         Significant Customers                               HTML     26K 
50: R18         Summary of Significant Accounting Policies          HTML    162K 
                (Policies)                                                       
55: R19         Summary of Significant Accounting Policies          HTML     48K 
                (Tables)                                                         
70: R20         Discontinued Operations (Tables)                    HTML     51K 
61: R21         Convertible Debt and Equity Financings (Tables)     HTML     51K 
43: R22         Derivative Liabilities (Tables)                     HTML     38K 
54: R23         Stockholders' Deficit (Tables)                      HTML    300K 
45: R24         Income Taxes (Tables)                               HTML     59K 
22: R25         Loss Per Share (Tables)                             HTML     50K 
62: R26         Commitments and Contingent Liabilities (Tables)     HTML     41K 
67: R27         Nature of Operations (Details Textual)              HTML     47K 
31: R28         Summary of Significant Accounting Policies          HTML     34K 
                (Details)                                                        
30: R29         Summary of Significant Accounting Policies          HTML     44K 
                (Details 1)                                                      
34: R30         Summary of Significant Accounting Policies          HTML    105K 
                (Details Textual)                                                
35: R31         Discontinued Operations (Details)                   HTML     65K 
37: R32         Convertible Debt and Equity Financings (Details)    HTML     59K 
21: R33         Convertible Debt and Equity Financings (Details     HTML    197K 
                Textual)                                                         
60: R34         Derivative Liabilities (Details)                    HTML     35K 
42: R35         Derivative Liabilities (Details Textual)            HTML     56K 
44: R36         Stockholders' Deficit (Details)                     HTML    109K 
25: R37         Stockholders' Deficit (Details 1)                   HTML     44K 
69: R38         Stockholders' Deficit (Details 2)                   HTML     39K 
17: R39         Stockholders' Deficit (Details 3)                   HTML     52K 
38: R40         Stockholders' Deficit (Details 4)                   HTML    181K 
64: R41         Stockholders' Deficit (Details 5)                   HTML     81K 
24: R42         Stockholders' Deficit (Details Textual)             HTML    529K 
29: R43         Income Taxes (Details)                              HTML     49K 
33: R44         Income Taxes (Details1)                             HTML     47K 
40: R45         Income Taxes (Details Textual)                      HTML     28K 
20: R46         Related Party Transactions (Details Textual)        HTML    546K 
26: R47         Loss Per Share (Details)                            HTML     57K 
18: R48         Commitments and Contingent Liabilities (Details)    HTML     61K 
63: R49         Commitments and Contingent Liabilities (Details     HTML     83K 
                Textual)                                                         
23: R50         Significant Customers (Details Textual)             HTML     24K 
68: XML         IDEA XML File -- Filing Summary                      XML     95K 
19: EXCEL       IDEA Workbook of Financial Reports                  XLSX    215K 
28: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.17M 
11: EX-101.INS  XBRL Instance -- cnso-20140930                       XML   2.73M 
13: EX-101.CAL  XBRL Calculations -- cnso-20140930_cal               XML    142K 
14: EX-101.DEF  XBRL Definitions -- cnso-20140930_def                XML   1.23M 
15: EX-101.LAB  XBRL Labels -- cnso-20140930_lab                     XML   1.45M 
16: EX-101.PRE  XBRL Presentations -- cnso-20140930_pre              XML   1.35M 
12: EX-101.SCH  XBRL Schema -- cnso-20140930                         XSD    274K 
32: ZIP         XBRL Zipped Folder -- 0001144204-14-076185-xbrl      Zip    225K 




        
Filing Submission 0001144204-14-076185 – SGML Text

Original SGML Text submitted by:  Toppan Merrill/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 10:37:23.2pm ET